Development of experimental microfluidic device and methodology for assessing microrheological properties of blood
Clinical Hemorheology and Microcirculation · 07.04.2023 · 83 (3) · 231-245
DOI: 10.3233/ch-221631 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Hemorheology and Microcirculation, online erschienen am 23.12.2022. Verfasst von Nadia Antonova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomechanics, Institute of Mechanics, Bulgarian Academy of Sciences, Sofia, Bulgaria. Hauptthemen laut MEDLINE: Microfluidics, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVE: Microfluidics is a useful tool for investigating blood microrheology. The study aimed to present the development of a microfluidic device for assessing the microrheological properties of blood cells’ suspensions and its application in patients with diabetes mellitus type 2 (T2DM). METHODS: A new microfluidic device was elaborated, connected to a system, including a microscope with a digital camera, a pump with a manometer and a computer with specially developed software. Blood cells’ suspensions were investigated in a microchamber between two parallel optical slides within a 100μm distance. The motion of the blood cells in the microchamber was observed by the microscope and it was recorded and visualized by a digital camera. A method for evaluating the deformability of blood cells and a device for its implementation were used [ 1 ]. RESULTS: The pressure and flow rate ranges in the microfluidic device were specified by model suspensions of beta-ferroxy-hydroxide and red blood cells (RBC) suspensions. The pressure changes, realized by a pump (micropipette), connected to a manometer were established and the corresponding shear rates in the microfluidic device were determined. Data about the blood microrheological properties like RBC aggregation and deformability, leukocyte adhesion from a group of healthy volunteers and from patients with T2DM were obtained. CONCLUSIONS: The developed device and experimental system is a promising tool for the study of blood microrheology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomechanics, Institute of Mechanics, Bulgarian Academy of Sciences, Sofia, Bulgaria.
- Department of Interfaces and Colloids, Institute of Physical Chemistry, Bulgarian Academy of Sciences, Sofia, Bulgaria.
- Department of Medicine and Biology, Yaroslavl State Pedagogical University, Yaroslavl, Russia.
- Uni Hospital, Panagyurishte, Bulgaria.
Zitieren
APA
Antonova, N., Khristov, K., Alexandrova, A., Muravyov, A., & Velcheva, I. (2023). Development of experimental microfluidic device and methodology for assessing microrheological properties of blood. Clinical Hemorheology and Microcirculation, 83(3), 231-245. https://doi.org/10.3233/ch-221631
Vancouver
Antonova N, Khristov K, Alexandrova A, Muravyov A, Velcheva I. Development of experimental microfluidic device and methodology for assessing microrheological properties of blood. Clinical Hemorheology and Microcirculation. 2023;83(3):231-245. doi:10.3233/ch-221631
BibTeX
@article{Antonova2023,
author = {Antonova, Nadia and Khristov, Khristo and Alexandrova, Anika and Muravyov, Alexei and Velcheva, Irena},
title = {Development of experimental microfluidic device and methodology for assessing microrheological properties of blood},
journal = {Clinical Hemorheology and Microcirculation},
year = {2023},
volume = {83},
number = {3},
pages = {231--245},
doi = {10.3233/ch-221631}
}
EUVIMED